Skip to Main Content

Paper Details

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival.
JCO Precis Oncol
2
2023
Author NameAffiliation
Jianjun ZhangThe University of Texas MD Anderson Cancer Center
Daniel R GomezMemorial Sloan Kettering Cancer Center
Steven H LinThe University of Texas MD Anderson Cancer Center
Steven H LinThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2